Tilt Hldgs Inc Stock Price, News & Analysis

TILT Holdings (OTCID: TLLTF) announced it has entered a restructuring support agreement with holders of its senior secured notes and obtained an initial order under the CCAA from the Supreme Court of British Columbia. The Court appointed PricewaterhouseCoopers as Monitor, granted a stay of proceedings and allowed the company to raise up to US$2.0 million of bridge notes from existing noteholders to fund operations during the process. The proposed Plan would take the company private by cancelling existing equity and issuing equity to noteholders, and a Noteholders meeting is anticipated on Nov 17, 2025. Trading of common shares is halted and delisting is anticipated.

The Board remains in place; subsidiaries will continue regular operations.

TILT Holdings (OTCID: TLLTF), a global cannabis business solutions provider, has completed the sale of two Massachusetts dispensaries to In Good Health for $1.75 million. This transaction, initially announced on February 3, 2025, is part of TILT's strategic alternatives review.

Under the agreement, In Good Health will operate the Taunton location, while the Brockton dispensary has been closed. Highgate Capital Partners served as the broker for this transaction, which represents a significant step in TILT's strategic review process.

TILT Holdings (OTCID: TLLTF) reported Q2 2025 results, highlighting its strategic transformation into an asset-light business focused on its Jupiter vaporization hardware segment. Revenue from continuing operations was $10.5 million, down from $19.0 million year-over-year, with a net loss of $9.2 million.

Key developments include receiving regulatory approval for Massachusetts dispensary sale, establishing a management agreement with MariMed for Standard Farms Pennsylvania, and achieving EU MDR certification for their QMID™ handheld vaporizer. The company maintains $2.0 million in cash and equivalents, received a $3.5 million IRS refund for Employee Retention Credit, and reported an Adjusted EBITDA of $(2.0) million.

TILT Holdings (TLLTF) held its 2025 Annual General Meeting virtually on June 17, 2025, where shareholders approved key proposals. The meeting resulted in the election of five directors: John Barravecchia, Tim Conder, Marshall Horowitz, George Odden, and Arthur Smuck, each receiving significant majority support with votes ranging from 26.9M to 27.6M in favor. Additionally, shareholders approved the re-appointment of Haynie & Company as the company's auditors, with 71M votes in favor, 18.7M against, and 1.7M abstentions. The Board has been authorized to determine the auditors' remuneration.

TILT Holdings (TLLTF) reported Q1 2025 financial results, showing a decline in performance with revenue dropping to $22.7M from $37.5M year-over-year. The company posted a net loss of $13.2M, wider than the $9.7M loss in the prior year. Gross margin decreased to 14.9% from 17.9%, while Adjusted EBITDA was negative at $(974)K compared to $38K last year. The company is executing a strategic transformation to become a Jupiter-first business by divesting plant-touching assets. Key developments include signing a $2M agreement to sell two Massachusetts dispensaries and achieving EU medical device certification for Jupiter's QMID vaporizer. TILT is shifting Jupiter production to Indonesia to reduce costs and recently added a new East Coast MSO customer as an exclusive vape hardware partner. Despite lower overall performance, the company maintained stable cash positions at $4.3M and improved operating cash flow to $1.9M compared to -$2.4M in the previous year.

Curaleaf International and Jupiter Research (TLLTF) have secured EU medical device certification for Europe's first handheld liquid inhalation device designed for medical cannabis administration. The device, certified as a Class IIa medical device under EU Regulation 2017/745, features a magnetic snap-in cartridge and rechargeable power supply for consistent cannabinoid delivery.

The certification enables commercialization across multiple global markets, including European countries, the UK, Canada, and Australasia. The device's technical file and EU Declaration of Conformity were approved by an EU Notified Body, validating its quality, safety, and clinical effectiveness.

TILT Holdings (OTCPK: TLLTF) has scheduled its first quarter 2025 earnings conference call for May 15, 2025, at 5:00 p.m. ET. The company, a global provider of cannabis business solutions specializing in inhalation technologies, cultivation, manufacturing, processing, brand development and retail, will release its financial results for the quarter ended March 31, 2025, prior to the call.

The conference call will feature TILT management presenting the company's business strategy and financial results, followed by a Q&A session. Participants can join using the toll-free number (877) 423-9813 or international number (201) 689-8573. A webcast replay will be available in the investor relations section of TILT's website.

TILT Holdings (OTCQB: TLLTF) has received default notices from Innovative Industrial Properties (IIP) subsidiaries for two properties due to outstanding rental payments. The defaults concern properties in White Haven, PA and Taunton, MA.

The White Haven property default amounts to $1,130,592.57 in unpaid base rent, additional rent, and security deposit. The Taunton property default totals $2,996,786.42, including base rent, additional rent, late charges, interest, and security deposit.

Following the notices, TILT has initiated negotiations with IIP and has made payments for April rent obligations. IIP accepted these payments in exchange for forbearance from pursuing termination and eviction. TILT states it is committed to negotiating to resolve the outstanding amounts.

TILT Holdings (OTCQB: TLLTF) reported its Q4 and full-year 2024 financial results, marking a transformative year focused on streamlining operations. Q4 revenue declined to $24.6 million from $37.5 million year-over-year, primarily due to Jupiter Hardware business performance. The company posted a Q4 net loss of $41.4 million, compared to $22.0 million loss in the prior year period.

Full-year 2024 results showed revenue of $115.6 million, down from $166.0 million in 2023, with a net loss of $99.7 million compared to $62.4 million loss in the previous year. The company is divesting its Massachusetts retail assets for $2 million, with regulatory approvals expected in Q2 2025, as part of its strategy to focus on Jupiter operations.

The company ended the year with $4.3 million in cash and equivalents, compared to $3.3 million at the end of 2023. Notes payable increased to $72.1 million from $52.2 million year-over-year.